You are here

vaccines

He experienced a severe reaction to Moderna’s Covid-19 vaccine candidate. He’s still a believer

He experienced a severe reaction to Moderna’s Covid-19 vaccine candidate. He’s still a believer

Stat

Moderna Therapeutics

clinical trials

Flag link:

Oxford Uni coronavirus vaccine ‘has 50% chance of success’

Oxford Uni coronavirus vaccine ‘has 50% chance of success’

Pharmaforum

University of Oxford

clinical trials

Flag link:

FDA veteran reassigned to vaccine efforts

FDA veteran reassigned to vaccine efforts

Beckers Hospital Review

Flag link:

Novavax Is Beginning Clinical Trials Of Its Coronavirus Vaccine

Novavax Is Beginning Clinical Trials Of Its Coronavirus Vaccine

Forbes

clinical trials

Flag link:

Can Moderna Win the Race to Find a COVID-19 Vaccine?

Can Moderna Win the Race to Find a COVID-19 Vaccine?

Motley Fool

Moderna Therapeutics

Flag link:

AstraZeneca's COVID-19 vaccine enters phase 2/3 clinical trial

AstraZeneca's COVID-19 vaccine enters phase 2/3 clinical trial

Fierce Biotech

University of Oxford

clinical trials

Flag link:

Moderna Shares Up Almost 250% This Year as Vaccine Trials Continue

Moderna Shares Up Almost 250% This Year as Vaccine Trials Continue

Motley Fool

Flag link:

AstraZeneca Receives $1 Billion From U.S. Government To Produce Oxford Coronavirus Vaccine

AstraZeneca Receives $1 Billion From U.S. Government To Produce Oxford Coronavirus Vaccine

Forbes

federal government

University of Oxford

Flag link:

Harvard animal studies suggest COVID-19 protection can come from previous infection or DNA vaccine

Harvard animal studies suggest COVID-19 protection can come from previous infection or DNA vaccine

Fierce Biotech

Flag link:

AstraZeneca signed up to deliver U.K. shots first. Now it aims to supply COVID-19 vaccine worldwide: report

AstraZeneca signed up to deliver U.K. shots first. Now it aims to supply COVID-19 vaccine worldwide: report

Fierce Pharma

University of Oxford

Flag link:

More questions than answers as Moderna's coronavirus vaccine speeds ahead

More questions than answers as Moderna's coronavirus vaccine speeds ahead

BioPharma Dive

Moderna Therapeutics

clinical trials

Flag link:

Moderna Plans to Raise $1.25 Billion in a Secondary Offering

Moderna Plans to Raise $1.25 Billion in a Secondary Offering

Motley Fool

Moderna Therapeutics

Flag link:

AstraZeneca Aims for 30 Million Doses of COVID-19 Vaccine for U.K. by September

AstraZeneca Aims for 30 Million Doses of COVID-19 Vaccine for U.K. by September

BioSpace

University of Oxford

Flag link:

Moderna Reveals ‘Positive’ Data In Coronavirus Vaccine Trial, Markets Spike

Moderna Reveals ‘Positive’ Data In Coronavirus Vaccine Trial, Markets Spike

Forbes

Moderna Therapeutics

clinical trials

Flag link:

Did The Oxford Covid Vaccine Work In Monkeys? Not Really

Did The Oxford Covid Vaccine Work In Monkeys? Not Really

Forbes

University of Oxford

Flag link:

Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna Stand

Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna Stand

Yahoo/Benzinga

University of Oxford

Moderna Therapeutics

Flag link:

GreenLight Biosciences Raises $17 Million to Scale Up COVID-19 Vaccine Manufacturing

GreenLight Biosciences Raises $17 Million to Scale Up COVID-19 Vaccine Manufacturing

BioSpace

GreenLight Biosceinces

Flag link:

Novartis CEO: COVID-19 vaccine might take until end of 2021 to reach patients

Novartis CEO: COVID-19 vaccine might take until end of 2021 to reach patients

Fierce Pharma

Flag link:

COVID-19 vaccine row escalates as Macron calls meeting with Sanofi’s CEO

COVID-19 vaccine row escalates as Macron calls meeting with Sanofi’s CEO

Pharmaforum

Flag link:

Rick Bright details mismanaged pandemic response, warns of drugs, vaccine supply problems down the road

Rick Bright details mismanaged pandemic response, warns of drugs, vaccine supply problems down the road

Endpoints

Flag link:

Pages